Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
2000 1
2005 2
2013 1
2014 1
2018 2
2019 1
2020 1
2021 1
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
MicroRNA-associated carcinogenesis in lung carcinoma.
Pratap P, Raza ST, Abbas S, Mahdi F. Pratap P, et al. J Cancer Res Ther. 2018 Jan-Mar;14(2):249-254. doi: 10.4103/0973-1482.187283. J Cancer Res Ther. 2018. PMID: 29516903 Free article. Review.
Collective studies concern with research related to lung sarcoma by using biomarkers which determine phenotypic signatures on behalf of diagnostic, prognostic, as well as therapeutic rationale. Furthermore, a number of aspects are indispensable to be deliberated while opti …
Collective studies concern with research related to lung sarcoma by using biomarkers which determine phenotypic signatures on behalf of diag …
Stereotactic Body Radiation Therapy for Lung Metastases From Sarcoma in Oligometastatic Patients: A Phase 2 Study.
Navarria P, Baldaccini D, Clerici E, Marini B, Cozzi L, Franceschini D, Bertuzzi AF, Quagliuolo V, Torri V, Colombo P, Franzese C, Bellu L, Scorsetti M. Navarria P, et al. Int J Radiat Oncol Biol Phys. 2022 Nov 15;114(4):762-770. doi: 10.1016/j.ijrobp.2022.08.028. Epub 2022 Aug 18. Int J Radiat Oncol Biol Phys. 2022. PMID: 35987453 Clinical Trial.
The median OS time was 49 months (95% CI, 24-49 months), and the 1-, 2-, 3-, 4-, and 5-year OS rates were 88.6% 4.7%, 66.7 7.6%, 56.8% 8.4%, 53.0% 8.6%, and 48.2% 9.1%, respectively. Prognostic factors recorded as significantly affecting survival were age, grade of primary …
The median OS time was 49 months (95% CI, 24-49 months), and the 1-, 2-, 3-, 4-, and 5-year OS rates were 88.6% 4.7%, 66.7 7.6%, 56.8% 8.4%, …
Primary capicua transcriptional repressor-rearranged sarcoma of the lung.
Mizukami Y, Takahashi Y, Sugita S, Wakabayashi K, Suzuki H, Hasegawa T, Noguchi H, Adachi H. Mizukami Y, et al. Jpn J Clin Oncol. 2021 Apr 1;51(4):654-656. doi: 10.1093/jjco/hyaa240. Jpn J Clin Oncol. 2021. PMID: 33338234
Pulmonary CIC-rearranged sarcoma is extremely rare and has an unfavourable prognosis. However, complete resection can produce prognosis of long-term survival, and thus, surgery is an important option....
Pulmonary CIC-rearranged sarcoma is extremely rare and has an unfavourable prognosis. However, complete resection can produce prog …
Primary Pulmonary Synovial Sarcoma with Hemothorax: a Case Report.
AlQatari AA, Ahmed A, AlHije F, Sabry M, Elbawab H. AlQatari AA, et al. Med Arch. 2023;77(6):496-499. doi: 10.5455/medarh.2023.77.496-499. Med Arch. 2023. PMID: 38313103 Free PMC article.
The patient died after two years due to recurrence. CONCLUSION: PPSS is an aggressive disease with poor prognostic outcomes, and Its presentation is almost similar to other lung malignancies. ...
The patient died after two years due to recurrence. CONCLUSION: PPSS is an aggressive disease with poor prognostic outcomes, and Its …
Multimodality treatment including surgery for primary pulmonary sarcoma: Size does matter.
Collaud S, Stork T, Schildhaus HU, Pöttgen C, Plönes T, Valdivia D, Zaatar M, Dirksen U, Bauer S, Aigner C. Collaud S, et al. J Surg Oncol. 2020 Sep;122(3):506-514. doi: 10.1002/jso.25979. Epub 2020 May 14. J Surg Oncol. 2020. PMID: 32410271
Median disease-free survival was 17 months. Tumor size was a predictor for survival (P = .02) and recurrence (P = .05). Gender (P = .04) and type of lung resection (P = .04) were predictors of survival. T stage for STS of trunk and extremity, and TNM stage for lung …
Median disease-free survival was 17 months. Tumor size was a predictor for survival (P = .02) and recurrence (P = .05). Gender (P = . …
The tumor suppressor RASSF1A in human carcinogenesis: an update.
Dammann R, Schagdarsurengin U, Seidel C, Strunnikova M, Rastetter M, Baier K, Pfeifer GP. Dammann R, et al. Histol Histopathol. 2005 Apr;20(2):645-63. doi: 10.14670/HH-20.645. Histol Histopathol. 2005. PMID: 15736067 Review.
Inactivation of RASSF1A was associated with an advanced tumor stage (e.g. bladder, brain, prostate, gastric tumors) and poor prognosis (e.g. lung, sarcoma and breast cancer). Detection of aberrant RASSF1A methylation may serve as a diagnostic and prognostic marker. …
Inactivation of RASSF1A was associated with an advanced tumor stage (e.g. bladder, brain, prostate, gastric tumors) and poor prognosis …
Use of Radiation Therapy Within the Last Year of Life Among Cancer Patients.
Tseng YD, Gouwens NW, Lo SS, Halasz LM, Spady P, Mezheritsky I, Loggers E. Tseng YD, et al. Int J Radiat Oncol Biol Phys. 2018 May 1;101(1):21-29. doi: 10.1016/j.ijrobp.2018.01.056. Epub 2018 Jan 31. Int J Radiat Oncol Biol Phys. 2018. PMID: 29487025
This may be secondary to increased symptoms from advanced cancer toward the end of life. As patients with very poor prognoses (eg, within 30 days of death) are generally not included in RT clinical trials, further studies are warranted to assess whether PRT for bone metast …
This may be secondary to increased symptoms from advanced cancer toward the end of life. As patients with very poor prognoses (eg, wi …
Gross tumor volume segmentation for head and neck cancer radiotherapy using deep dense multi-modality network.
Guo Z, Guo N, Gong K, Zhong S, Li Q. Guo Z, et al. Phys Med Biol. 2019 Oct 16;64(20):205015. doi: 10.1088/1361-6560/ab440d. Phys Med Biol. 2019. PMID: 31514173 Free PMC article.
Furthermore, the proposed Dense-Net structure has less trainable parameters than the 3D U-Net, which reduces the prediction variability. In conclusion, our proposed multi-modality Dense-Net can enable satisfied GTV segmentation for HNC using multi-modality images and yield …
Furthermore, the proposed Dense-Net structure has less trainable parameters than the 3D U-Net, which reduces the prediction variabili …
Surgical treatment of primary sarcoma of the lung.
Porte HL, Metois DG, Leroy X, Conti M, Gosselin B, Wurtz A. Porte HL, et al. Eur J Cardiothorac Surg. 2000 Aug;18(2):136-42. doi: 10.1016/s1010-7940(00)00465-6. Eur J Cardiothorac Surg. 2000. PMID: 10925220
Presence of symptoms, tumour size (more or less than 5 cm), complete resection, TNM stage and histology grade were analyzed for predictors of survival. RESULTS: Patients comprised 11 women and seven men whose age ranged from 19 to 73 years (mean 50 years). ...
Presence of symptoms, tumour size (more or less than 5 cm), complete resection, TNM stage and histology grade were analyzed for predictor …
Bilateral anterior sternothoracotomy (clamshell incision): a suitable alternative for bilateral lung sarcoma metastasis in children.
Abbo O, Guatta R, Pinnagoda K, Joseph JM. Abbo O, et al. World J Surg Oncol. 2014 Jul 27;12:233. doi: 10.1186/1477-7819-12-233. World J Surg Oncol. 2014. PMID: 25064077 Free PMC article.
BACKGROUND: The aim of our study was to assess the postoperative course of bilateral anterior sternothoracotomy (BAT) in children with sarcoma metastases, in a curative care perspective. METHODS: We reviewed the records of seven patients younger than 18 years old, who unde …
BACKGROUND: The aim of our study was to assess the postoperative course of bilateral anterior sternothoracotomy (BAT) in children wit …
13 results